Investigating how Piezo1 contributes to joint stiffness in post-traumatic osteoarthritis
Piezo1-driven Synovial Fibrosis in Post-Traumatic Osteoarthritis
This study is looking at how a specific protein called Piezo1 affects joint stiffness and inflammation in people with post-traumatic osteoarthritis, with the hope of finding new ways to help manage the condition.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11182454 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of Piezo1, a mechanosensitive ion channel, in the development of synovial fibrosis associated with post-traumatic osteoarthritis (PTOA). By examining how Piezo1 influences signaling pathways that lead to increased stiffness in the joint lining, the study aims to uncover the mechanisms behind the worsening of PTOA symptoms. The researchers will analyze the behavior of synovial fibroblasts under mechanical stress to determine how they contribute to inflammation and fibrosis. This work could provide insights into new therapeutic targets for managing PTOA.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have developed post-traumatic osteoarthritis following a joint injury.
Not a fit: Patients with osteoarthritis not related to trauma or those with other joint conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that alleviate joint stiffness and improve mobility for patients with post-traumatic osteoarthritis.
How similar studies have performed: While the specific role of Piezo1 in synovial fibrosis is being explored, similar research has shown promising results in understanding mechanosensitive pathways in other forms of arthritis.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Farrell, Easton — University of Michigan at Ann Arbor
- Study coordinator: Farrell, Easton
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.